We are live on ! Find out more
TBPH icon

Theravance Biopharma
TBPH

83 hedge funds and large institutions have $425M invested in Theravance Biopharma in 2015 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 32 increasing their positions, 21 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,700% more call options, than puts

Call options by funds: $96K | Put options by funds: $2K

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

89% more capital invested

Capital invested by funds: $226M → $425M (+$200M)

52% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 21

0% more funds holding

Funds holding: 83 → 83 (0)

0% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 12

Holders
83
Holders Change
–
Holders Change %
0%
% of All Funds
2.18%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
12
Increased
32
Reduced
21
Closed
12
Calls
$96K
Puts
$2K
Net Calls
+$94K
Net Calls Change
+$1.08M

Top Buyers

Rank Fund Capital Flow
1
WIM
Woodford Investment Management
United Kingdom
+$74.6M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$26.6M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$2.13M
4
GAM
Gotham Asset Management
New York
+$1.1M
5
RSCM
Rock Springs Capital Management
Maryland
+$674K

Top Sellers

Rank Fund Capital Flow
1
Norges Bank
Norges Bank
Norway
-$6M
2
CC
Clearline Capital
New York
-$5.68M
3
State Street
State Street
Massachusetts
-$4.03M
4
RP
Reinhart Partners
Wisconsin
-$1.8M
5
RA
Royce & Associates
New York
-$1.67M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIP
76
Ameritas Investment Partners
Nebraska
$3K +$3.62K +228 New
TRCT
77
Tower Research Capital (TRC)
New York
$2K +$1.97K +124 New
US Bancorp
78
US Bancorp
Minnesota
$1K -$42.1K -2,656 -98%
IA
79
IFP Advisors
Florida
$1K +$905 +57 New
Manulife (Manufacturers Life Insurance)
80
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$273 +$5.59K +352 +2%
CC
81
Clearline Capital
New York
– -$5.68M -516,804 Closed
RP
82
Reinhart Partners
Wisconsin
– -$1.8M -164,249 Closed
TI
83
Trexquant Investment
Connecticut
– -$604K -55,000 Closed
RC
84
Roundview Capital
New Jersey
– -$412K -37,485 Closed
FAM
85
Fred Alger Management
New York
– -$347K -31,600 Closed
ARC
86
Absolute Return Capital
Massachusetts
– -$260K -23,701 Closed
Susquehanna International Group
87
Susquehanna International Group
Pennsylvania
– -$226K -20,563 Closed
PP
88
PDT Partners
New York
– -$194K -17,683 Closed
AC
89
Amici Capital
New York
– -$63K -5,705 Closed
Axa
90
Axa
France
– -$35K -3,200 Closed
WEC
91
Winslow Evans & Crocker
Massachusetts
– -$1.73K -158 Closed
SEI Investments
92
SEI Investments
Pennsylvania
– -$143 -9 -82%
AIA
93
Allegis Investment Advisors
Idaho
– +$111 +7 New
1 2 3
4

TBPH Hedge Fund Activity: Q4 2015 in Review

83 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Theravance Biopharma (TBPH) for Q4 2015, worth a combined $425M — up 89% from $226M a quarter earlier.

Fund positioning in TBPH was balanced in Q4 2015: 12 funds opened new positions, 12 closed out, 32 added to existing stakes and 21 trimmed.

The largest buyer was Woodford Investment Management, adding an estimated $74.6M. The largest seller was Norges Bank, cutting an estimated $6M.

  • 83 institutional investors held Theravance Biopharma (TBPH) as of Q4 2015, unchanged from Q3 2015.
  • Funds reported $425M of Theravance Biopharma stock for Q4 2015, up 89% quarter-over-quarter.
  • 12 funds opened new Theravance Biopharma positions in Q4 2015 and 12 closed out, a net change of 0 holders.
  • The largest Theravance Biopharma buyer in Q4 2015 was Woodford Investment Management, an estimated $74.6M added.
  • The largest Theravance Biopharma seller in Q4 2015 was Norges Bank, an estimated $6M sold.

Based on aggregated 13F filings for Q4 2015.